Chloroquine, hydroxychloroquine and COVID-19

The media have featured the antimalarials chloroquine (CQ) and hydroxychloroquine (HCQ) to treat coronavirus (COVID-19). Political leaders have touted their use and recommended availability to the public. These anti-inflammatory agents have substantial human toxicity with a narrow therapeutic window...

Descripción completa

Detalles Bibliográficos
Autores principales: Erickson, T. B., Chai, P. R., Boyer, E. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250427/
https://www.ncbi.nlm.nih.gov/pubmed/32457932
http://dx.doi.org/10.1080/24734306.2020.1757967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250427/
https://www.ncbi.nlm.nih.gov/pubmed/32457932
http://dx.doi.org/10.1080/24734306.2020.1757967

Ejemplares similares